Introduction
Labor contractions, causing alterations in intrauterine pressure, can affect uterine and umbilical blood flow (1) (2) (3) (4) (5) . Fluctuations in blood flow towards the fetus may negatively influence fetal oxygenation and fetal heart rate (FHR) through several complex pathways (2) (3) (4) (5) . Hence, abnormal FHR patterns, for example FHR decelerations
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A simulation model is used to gain insight into fetal condition during labor. The effect of maternal hyperoxygenation on fetal heart rate and oxygenation is simulated; our model shows that maternal hyperoxygenation may be beneficial to the fetus. induced by labor contractions, may be a sign of fetal hypoxia (6) (7) (8) . Prolonged fetal hypoxia may lead to hypoxic-ischemic encephalopathy and fetal death (9) . Therefore, when fetal distress is suspected, attempts to improve fetal oxygenation should be made before immediate delivery is indicated.
Former studies described several techniques to improve fetal condition, although little evidence is available to prove the beneficial effect of these techniques on neonatal outcome (10) (11) (12) . Maternal hyperoxygenation is often used to increase oxygen transport towards the fetus. In the last decades, several studies on the effect of maternal hyperoxygenation on fetal condition have been performed, mainly in the non-compromised fetus. Clinical trials performed so far provide contradictory results (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . A recent Cochrane review (20) concludes that "there is not enough evidence to support the use of prophylactic oxygen therapy for women in labor, nor to evaluate its effectiveness for fetal distress", because of the lack of a randomized controlled trial to investigate the effect of maternal hyperoxygenation on fetal condition.
Therefore, a randomized controlled trial would help us to investigate the effect of maternal hyperoxygenation. It makes more sense to design a randomized controlled trial once it has been clarified how maternal hyperoxygenation affects fetal oxygenation and FHR. Simulation models provide the possibility to investigate complex clinical situations, such as feto-maternal oxygenation.
Recently, our group developed a mathematical computerized simulation model to provide insight into the complex pathways affecting feto-maternal oxygenation and FHR (23) (24) (25) . The model is based on physiological parameters that influence oxygenation and FHR. These include maternal cardiac output, maternal oxygenation, uterine pressure and flow, oxygen diffusion capacity in the placenta, fetal cerebral blood flow, fetal oxygen consumption, and baroreceptor and chemoreceptor responses. This study aimed first to demonstrate how we used this simulation model to study feto-maternal oxygenation and FHR patterns during labor. Second, we demonstrate how we used the model to study the effect of maternal hyperoxygenation during decelerative FHR patterns.
Material and methods
A mathematical feto-maternal oxygenation model was developed by our group and implemented in MATLAB R2012a (MathWorks Inc., Natick, MA, USA) (23) (24) (25) . The model is based on physiological principles and consists of several modules (Figure 1) .
First, the cardiovascular system of mother and fetus are modeled. The model includes cardiac function, blood flow, volume and pressure at different locations in the feto-maternal circulation. In the maternal circulation, the uterine compartment is explicitly modeled and the other organs are lumped into the systemic compartment. In the fetal circulation, the systemic and umbilical compartments, as well as the cerebral compartment are explicitly modeled.
Second, an oxygen distribution model is used to calculate oxygen concentrations in all compartments in the feto-maternal circulation. Oxygen transport from the mother to the fetus is dependent on maternal oxygenation, oxygen diffusion capacity in the placenta, fetal oxygen consumption, and feto-placental blood flows and volumes. Maternal arteries supply oxygenated blood into the intervillous space of the placenta. Diffusion of oxygen from the maternal to the fetal part of the placenta is dependent on the oxygen pressure difference between the intervillous space and chorionic villi and on the diffusion capacity of the placental membrane. Oxygen-rich blood from the villous capillaries mixes with venous blood before entering the fetal heart and the arterial circulation. Arterial blood flows to the cerebral and systemic circulation where oxygen is consumed by metabolic uptake, after which it returns to the venous system. In addition, arterial blood enters the umbilical circulation and placenta, where new oxygen uptake takes place.
Third, cardiovascular regulation is provided by the fetal baroreceptors and chemoreceptors, which monitor fetal blood pressure and oxygen pressure, respectively. Stimulation of these receptors leads to changes in parasympathetic and sympathetic activity, which can then induce Finally, uterine contractions are simulated by a contraction generator. Characteristics of the contractions can be set by the user to investigate the effect of contraction strength, duration and interval. Intrauterine pressure changes may lead to alterations in fetal and maternal vascular resistances through the compression of blood vessels, so affecting blood oxygenation, (local) blood pressure and flow.
In the model, we applied uniform uterine contractions, causing variable or late decelerations. For a complete description of inducing variable and late decelerations, we refer to previous publications (24, 25) .
We first simulated variable decelerations via contraction-induced umbilical cord compression (contraction duration 60 s, peak strength 70 mmHg) with a varying contraction interval (90, 60 or 45 s). For each simulation, the first uterine contraction was applied during maternal normoxia level [partial oxygen pressure (PO 2 ) of 98 mmHg] (16). After the first contraction, we simulated 100% oxygen administration to the mother via a nonrebreathing mask by a gradual increase to a maternal PO 2 steady state of 475 mmHg, as reported by Vasicka et al. (16) . We repeated this exact procedure during the simulation of late decelerations via contraction-induced uterine flow reduction for a placenta with 50% reduction in oxygen diffusion capacity.
The primary outcome measure is the difference in feto-placental PO 2 before and after maternal hyperoxygenation in the presence of variable or late decelerations. We compared PO 2 the intervillous space, fetal arteries, umbilical vein and arteries and the fetal cerebral and microcirculation. Second, we compared the difference in duration and depth of FHR decelerations during maternal normoxia and hyperoxia, as a reaction to contractions with a different interval.
As no human or animal subjects were involved in this study, no ethics approval is required according to the Declaration of Helsinki.
Statistical analysis
The simulation model represents one mother and one fetus, with fixed output values per simulation, hence no statistical analysis can be performed.
Results

Figure 2 demonstrates
in all feto-placental compartments increases. Maternal hyperoxygenation has a greater effect on fetal PO 2 when intervals are longer. When the contraction interval is 90 s, PO 2 increases most in the intervillous space (from 43 to 54 mmHg). The increase is less pronounced in the cerebral circulation, where PO 2 increases from 15 to 17 mmHg. When the contraction interval is only 45 s, the increase in PO 2 is less explicit in both the intervillous space and cerebral circulation (from 43 to 52 mmHg and from 14 to 15 mmHg, respectively).
Figures 3a-c demonstrate the effect of maternal hyperoxygenation during variable decelerations on PO 2 in fetal arteries and FHR. At the end of each uterine contraction, fetal PO 2 quickly increases due to a temporary increase in oxygenated blood flow toward the fetus as cord compression is discontinued. Maternal hyperoxygenation leads to a quicker recovery of FHR to baseline level compared with maternal normoxia, except when the contraction interval is very short (45 s). For all intervals the drop in FHR is less severe during maternal hyperoxygenation: deceleration depth decreases from 45 to 20 beats per minute. Figure 4 demonstrates PO 2 in different feto-placental compartments during late decelerations in relation to uterine contractions occurring with an interval of 90, 60 or 45 s. During hyperoxygenation, as in the presence of variable decelerations, PO 2 in all feto-placental compartments increases. Maternal hyperoxygenation has a greater effect on fetal PO 2 when intervals are longer. When the contraction interval is 90 s, PO 2 particularly increases in the intervillous space (45-55 mmHg). The increase is less pronounced in the cerebral circulation and microcirculation, where PO 2 increases from 15 to 17 mmHg. When the contraction interval is only 45 s, in the intervillous space, cerebral circulation and microcirculation, the profit is less explicit (from 45 to 52 mmHg in the intervillous space and from 15 to 16 mmHg in both the cerebral and microcirculation).
Figures 5a-c demonstrate the effect of maternal hyperoxygenation during late decelerations on fetal oxygenation and FHR. There is no difference in time to recovery to baseline level and no substantial decrease in deceleration depth during maternal hyperoxia compared with maternal normoxia.
Discussion
The model simulates a decrease in fetal oxygenation and FHR decelerations as a result of uterine contractions. Simulation of maternal hyperoxygenation with 100% oxygen shows an increase in PO 2 in all fetal and placental compartments, with the largest increase in the intervillous space and the smallest increase in the cerebral circulation. The fetus benefits more from oxygen administration to the mother when contraction intervals are longer. This observation is noticed in the presence of both variable and late decelerations, and can be explained by the physiological situation where oxygen transfer towards the placenta and the fetus continues for a longer period of time, leading to an increase in final PO 2 . Amelioration of the FHR pattern only occurs in the presence of variable decelerations.
The beneficial effect of maternal hyperoxygenation on fetal oxygenation and FHR is less pronounced during late decelerations. Late decelerations are often a sign of impaired placental function and severe fetal distress. Due to an impaired oxygen diffusion capacity of the placental membrane, the effect of maternal hyperoxygenation is less distinct than in variable decelerations where placental function is normal. It is possible that the level of increase of fetal PO 2 during late deceleration does not reach the threshold to considerably improve FHR.
A small number of clinical trials investigating the effect of maternal hyperoxygenation on fetal oxygenation and FHR have been published. However, only a few of these studies are performed in the compromised fetus. In accordance with our findings, Althabe et al. (13) demonstrated that 100% oxygen administration to the mother of a fetus with a nonreassuring FHR pattern has a beneficial effect: both FHR pattern and PO 2 in the peripheral circulation (fetal buttock) improve after 1 minute of oxygen administration. In addition, Haydon et al. (17) showed an increase in fetal oxygen saturation using 40 and 100% maternal inspired oxygen in the case of nonreassuring FHR patterns in 24 pregnant women. The increase in PO 2 did not result in consistent changes in FHR patterns, but the authors recommended to further investigate these changes using a study with a larger study group. Hidaka et al. (14) investigated the recovery from type II dips by oxygen inhalation. Type II dips are nowadays described as late decelerations (2) . During the first stage of labor, maternal hyperoxygenation successfully recovered FHR in 30% of the cases, even though the fraction of inspired oxygen supplied remains unclear.
Sørensen et al. (26) performed blood oxygen leveldependent magnetic resonance imaging (BOLD MRI) in pregnant sheep under hypoxic, normoxic and hyperoxic conditions. An increase in BOLD MRI signal was assigned to an increase in fetal tissue PO 2 (liver, spleen and kidney). This study does not focus on the effect of fetal PO 2 on FHR. During maternal hyperoxygenation the BOLD MRI signal in fetal organs increases, suggesting an increase in tissue PO 2 . Interestingly, the increase in BOLD MRI signal in the fetal brain did not change under normoxic, hypoxic or hyperoxic conditions. This finding is ascribed to the brain-sparing mechanism of the fetus.
Based on our study results, as produced by the simulation model, it could be useful to apply maternal hyperoxygenation during labor in the presence of variable decelerations. In case of late decelerations, a positive effect on fetal oxygenation is demonstrated, but not as much as in variable decelerations. However, no effect on FHR decelerations is shown. It is possible that the level of increase in fetal PO 2 does not reach the threshold to considerably improve FHR. The effect of maternal hyperoxygenation in the presence of late FHR deceleration should be further investigated.
Careful considerations should be made with the translation of model results to clinical practice, since a simulation model is by definition a simplified representation of the complex feto-maternal physiology. Nevertheless, modeling results may be indicative for clinical fetal outcome and may give direction to hypothesis testing in clinical practice.
Our model can provide estimation of physiological parameters that cannot yet be measured in clinical practice, such as fetal oxygenation or blood pressure, thereby enhancing insight into the physiological processes. This means that the model could be helpful in the formulation of hypotheses and subsequently in the design of clinical studies to evaluate the effect of resuscitation techniques.
Both patients and clinicians may benefit from the use of simulation models. The effect of clinical interventions during labor can be safely tested in a model, before women are exposed to therapeutic interventions. For example, the effect of administration of oxygen, fluids or medication can be investigated without risks for the mother or fetus.
When the simulation model indicates an adverse effect on fetal condition, this finding could be taken into account in the design of a clinical experiment, thereby improving women's safety. Moreover, simulations can be run over and over again, without exposing women to invasive procedures. Ultimately, the model has potential to be used as a clinical support tool in future, following a thorough sensitivity analysis. In its current status the model can be used for educational purposes such as simulation training.
From the study described above, we conclude that this simulation model indicates a beneficial effect of maternal hyperoxygenation on fetal oxygenation and FHR pattern in the presence of variable and -to a lesser extent -late FHR decelerations. We now plan a clinical trial comparing model data with clinical outcome.
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